APA

Forse C. L., Agarwal S., Pinnaduwage D., Gertler F., Condeelis J. S., Lin J., Xue X., Johung K., Mulligan A. M., Rohan T. E., Bull S. B. & Andrulis I. L. (20160222). Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. : BMC cancer.

Chicago

Forse Catherine L, Agarwal Seema, Pinnaduwage Dushanthi, Gertler Frank, Condeelis John S, Lin Juan, Xue Xiaonan, Johung Kimberly, Mulligan Anna Marie, Rohan Thomas E, Bull Shelley B and Andrulis Irene L. 20160222. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. : BMC cancer.

Harvard

Forse C. L., Agarwal S., Pinnaduwage D., Gertler F., Condeelis J. S., Lin J., Xue X., Johung K., Mulligan A. M., Rohan T. E., Bull S. B. and Andrulis I. L. (20160222). Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. : BMC cancer.

MLA

Forse Catherine L, Agarwal Seema, Pinnaduwage Dushanthi, Gertler Frank, Condeelis John S, Lin Juan, Xue Xiaonan, Johung Kimberly, Mulligan Anna Marie, Rohan Thomas E, Bull Shelley B and Andrulis Irene L. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. : BMC cancer. 20160222.